Pfizer warns FDA of shrinking penicillin supply

Pfizer warns of impending shortage of syphilis treatment drug as infections rise

Pfizer, a pharmaceutical company, has issued a warning regarding a potential shortage of Bicillin L-A, a drug used to treat syphilis and bacterial infections in children.

Pfizer warns FDA of shrinking penicillin supply

Pfizer cited a "complex combination of factors" for the shortage, including an increase in demand and a rise in syphilis rates.

Pfizer warns FDA of shrinking penicillin supply

Pfizer cited a "complex combination of factors" for the shortage, including an increase in demand and a rise in syphilis rates.

Pfizer warns FDA of shrinking penicillin supply

Pfizer cited a "complex combination of factors" for the shortage, including an increase in demand and a rise in syphilis rates.

Pfizer warns FDA of shrinking penicillin supply

Pfizer cited a "complex combination of factors" for the shortage, including an increase in demand and a rise in syphilis rates.

Pfizer warns FDA of shrinking penicillin supply

(The Hill) -- The ongoing drug shortages impacting the U.S. are now threatening to exhaust two commonly used forms of penicillin, Pfizer said in a warning to the Food and Drug Administration (FDA) on Monday. Pfizer alerted the FDA that there is "a limited supply and impending stock out" of Bicillin L-A and Bicillin C-R, two of its injectable penicillin products. Get the latest, news, weather, sports and community events delivered right to y…